Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Vigabatrin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Vigabatrin SCHEMBL9132153 | 1.00 | — | — | |
| Vigabatrin SCHEMBL5785801 | 1.00 | CYP2D6 (1.00) | — | |
| Vigabatrin SCHEMBL26714 | 1.00 | — | — | |
| Vigabatrin SCHEMBL31159534 | 1.00 | — | — | |
| Vigabatrin SCHEMBL20659806 | 0.98 | CYP2D6 (0.95) | — | |
| Vigabatrin SCHEMBL17372729 | 0.88 | BLM (0.78) | — | |
| Valproic Acid SCHEMBL2372220 | 0.84 | SLC6A3 (0.70) | — | |
| Hydrochloric Acid SCHEMBL31483557 | 0.79 | BLM (0.65) | — | |
| SCHEMBL15396442 | 0.79 | — | — | |
| SCHEMBL8058851 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 773 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | claimed |
| EP-4181891-B1 | USE OF CANNABIDIOL IN THE TREATMENT OF ABSENCE SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO BRAIN INJURY | JAZZ PHARMACEUTICALS RESEARCH UK LTD (GB) | 2025-12-17 | — | — | EP | claimed |
| EP-4043016-B1 | THE 5HT AGONIST CLEMIZOLE FOR USE IN TREATING EPILEPSY DISORDERS | UNIV CALIFORNIA (US) | 2025-10-29 | — | — | EP | claimed |
| EP-4181901-B1 | USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES | JAZZ PHARMACEUTICALS RESEARCH UK LTD (GB) | 2025-10-15 | — | — | EP | claimed |
| EP-3436000-B1 | USE OF CANNABINOIDS IN THE TREATMENT OF STURGE WEBER SYNDROME | JAZZ PHARMACEUTICALS RESEARCH UK LTD (GB) | 2025-07-16 | — | — | EP | claimed |
| EP-3917907-B1 | MODULATORS OF POTASSIUM ION CHANNELS AND USES THEREOF | UNIV DEGLI STUDI DI SALERNO (IT) | 2025-05-21 | — | — | EP | claimed |
| EP-4181899-B1 | USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES | JAZZ PHARMACEUTICALS RESEARCH UK LTD (GB) | 2025-05-21 | — | — | EP | claimed |
| EP-3518975-B1 | FORMULATION COMPRISING FENFLURAMINE AND CANNABIDIOL AND ITS USE IN THE TREATMENT OF SEIZURES | ZOGENIX INTERNATIONAL LTD (GB) | 2025-04-09 | — | — | EP | claimed |
| EP-3638673-B9 | TETRAHYDROPYRIDOPYRAZINE MODULATORS OF GPR6 | TAKEDA PHARMACEUTICALS CO (JP) | 2024-11-20 | — | — | EP | claimed |
| EP-3615010-B1 | METHODS FOR TREATING DRAVET SYNDROME | CAVION INC (US) | 2024-08-21 | — | — | EP | claimed |
| EP-1438019-A1 | KIT FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION | PARI GmbH Spezialisten für effektive Inhalation (DE) | 2004-07-21 | — | — | EP | claimed |
| EP-0956019-B1 | NOVEL THERAPEUTIC APPLICATION OF A THIENYCYCLOHEXYLAMINE DERIVATIVE | SOD CONSEILS RECH APPLIC (FR) | 2003-10-15 | — | — | EP | claimed |
| WO-2003035030-A1 | KIT FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION | PARI GMBH (DE) | 2003-05-01 | — | — | WO | claimed |
| WO-2003000643-A1 | NITRATE ESTER DERIVATIVES USEFUL FOR PREPARING DRUGS FOR EPILEPSY | NICOX S.A. (FR) | 2003-01-03 | — | — | WO | claimed |
| EP-1227856-A1 | INHALATION NEBULIZER | PARI GmbH Spezialisten für effektive Inhalation (DE) | 2002-08-07 | — | — | EP | claimed |
| WO-2001034232-A9 | INHALATION NEBULIZER | PARI GMBH (DE) | 2002-08-01 | — | — | WO | claimed |
| WO-2001034232-A1 | INHALATION NEBULIZER | Pari GmbH Spezialisten für effektive Inhalation (DE) | 2001-05-17 | — | — | WO | claimed |
| EP-0956019-A1 | NOVEL THERAPEUTIC APPLICATION OF A THIENYCYCLOHEXYLAMINE DERIVATIVE | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 1999-11-17 | — | — | EP | claimed |
| WO-1998024434-A1 | NOVEL THERAPEUTIC APPLICATION OF A THIENYCYCLOHEXYLAMINE DERIVATIVE | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 1998-06-11 | — | — | WO | claimed |
| EP-0463560-B1 | New antiepileptic agents | CIBA GEIGY AG (CH) | 1995-10-25 | — | — | EP | claimed |